Neurocrine Biosciences Inc vs Western Union Co — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Western Union Co trades at $8.9 (market cap $2.71B). The key difference: Neurocrine Biosciences Inc is far larger — about 6.4× Western Union Co's market cap, and Western Union Co pays a 10.85% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | WU | |
|---|---|---|
Market Cap | $17.40B | $2.71B |
Sector | Health | Technology |
52-Week High | $180.55 | $10.28 |
52-Week Low | $123.10 | $7.04 |
Enterprise Value | $16.49B | $2.40B |
Dividend Yield | — | 10.85% |
Trailing returns across standard periods
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →